Navigation Links
Grace Century Attends Provia Labs First Quarter Expansion Meeting January 5-10

Ras Al Khaimah, UAE (PRWEB) January 05, 2014

The executive team of UAE based international research and private equity consultancy, Grace Century, FZ LLC is in Boston, Massachusetts this week to attend Provia Laboratories' first quarterly meeting of 2014. The meeting is designed specifically to implement the next phase of the health services company's dental stem cell bio banking service.

According to Scott Wolf, CEO of Grace Century, this week's meeting will be much more than a typical quarterly meeting for Provia Labs and its bio-banking service, Store-A-Tooth.™ Upon moving into its new headquarters--triple the company’s previous space---and bringing all of its operations under one roof, Provia Labs has been able to simultaneously reduce fixed costs and accommodate dramatic growth. The company is ready for its planned North American, European, and Middle East expansion. "These are incredibly exciting times for Provia and its expansion. When we promote a firm, we believe that there is an obligation of oversight to our members that is ongoing. This will be our third visit to Provia," said Wolf.

"2013 was designed to prove our model works. With tremendous dental professional interest and acceptance, we have built not only an existing dentist network of over 6,000, but the model to replicate this nationwide," explains Provia Laboratories CEO, Howard Greenman. "While each geographical territory has its challenges, the common denominator is that there is tremendous demand by families to harvest and bank their children’s stem cells. The key is increasing awareness of their opportunities to do so from teeth."

Provia Labs is presently providing services directly or through collaborators in seven countries and three states in the U.S. The plan is to expand into ten states in 2014. Europe, the Caribbean, and possibly the Middle East will also be added in the New Year.

Besides the bio banking of dental stem cells, Provia has also completed numerous federal consulting contracts and provides bio-specimen containers to some of the world’s premier research facilities through its Proviasette® division.

About Grace Century, FZ LLC

Grace Century is an international research and private equity consultancy located in Ras Al Khaimah (north of Dubai) in the United Arab Emirates (UAE). Grace Century specializes in "game-changing" life science and health related private equity projects. For more information, visit:

About Provia Laboratories, LLC

Provia Laboratories is a health services company specializing in high quality stem cell bio banking (the collection, transport, processing, and cryogenic storage of biological specimens). Its dental stem cell banking service, Store-A-Tooth,™ gives parents the option to store stem cells today to protect their children’s health tomorrow. Store-A-Tooth™ preserves stem cells from baby and wisdom teeth that would otherwise be discarded, so parents can be prepared for advances in stem cell therapies that someday may help treat conditions such as type 1 diabetes, spinal cord injury, heart attack, stroke, and neurological disorders like Parkinson’s and Alzheimer’s. For more information about Store-A-Tooth™ dental stem cell banking, call 1-877-867-5753 or visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. National Press Club Celebration of the Publication of "The Grace of Stem Cells" by Jeong Chan Ra, Chairman of RNL BIO
2. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
3. Grace Century Attends Provia Laboratories Cycle II Launch
4. Dalia Dergham Joins Grace Century FZ LLC International Project Team
5. Grace Century, FZ LLC Publishes Annual Global and Regional Financial Predications for 2014
6. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
7. Stanford scientists spark new interest in the century-old Edison battery
8. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
9. Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference
10. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
11. MEI Pharma to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer and recently formed ... entered into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The ... gene editing across all applications. , Under the terms of the agreement, Pioneer ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... with the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s ... hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):